Skip to search boxSkip to navigationSkip to main content

Inhibition by dications of in vitro growth of Leishmania major and Leishmania tropica: Causative agents of old world cutaneous leishmaniasis

  • Alexa C. Rosypal
    ,
  • Karl A. Werbovetz
    ,
  • Manar Salem
    ,
  • Chad E. Stephens
    ,
  • Arvind Kumar
    ,
  • David W. Boykin
  • University of North Carolina at Chapel Hill
    ,
  • Ohio State University
    ,
  • Tanta University
    ,
  • Georgia State University
Scholary Output:
Contribution to journal
Article
Peer-review

Abstract

Old World cutaneous leishmaniasis is caused by infection with Leishmania major and Leishmania tropica. Pentamidine and related dications exhibit broad spectrum antiprotozoal activity. Based on the previously reported efficacy of these compounds against related organisms, 18 structural analogs of pentamidine were evaluated for in vitro antileishmanial activity, using pentamidine as the standard reference drug for comparison. Furan analogs and reversed amidine compounds were examined for activity against L. major and L. tropica promastigotes. The most active compounds against both Leishmania species were in the reversed amidine series. DB745 and DB746 exhibited the highest activity against L. major and DB745 was the most active compound against L. tropica. Both of these compounds exhibited 50% inhibitory concentrations (IC50) below 1 nM for L. major. Ten reversed amidines were also tested for their ability to inhibit growth in an axenic amastigote model. Nine of 10 reversed amidine analogs were active at concentrations below 1 nM. These results justify further study of dicationic compounds as potential new agents for treating cutaneous leishmaniasis.

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 743-749 (7 pages)

Journal (Volume, Issue Number)

Journal of Parasitology (Volume 94, Issue 3)

Publication milestones

  • Published - 06/2008

Publication status

Published - 06/2008

ISSN

0022-3395

Publication IDs

  • Scopus: 47349125360
  • PubMed: 18605790

Publication metrics

Metrics

SciVal
FWCI
1.08
SciVal
Author count
8
SciVal
citations
16
SciVal
Paper percentile
70
Scopus
citations
Fractional count
1
Fractional count
0.13
Fractional count
7
Fractional count
0.88
Fractional count
1
Fractional count
1

PlumX, opens in new tab

Captures
9
Citation count
19